Precision medicine in adult and pediatric obesity: a clinical perspective.

Therapeutic Advances in Endocrinology and Metabolism
Eric M BombergAaron S Kelly

Abstract

It remains largely unknown as to why some individuals experience substantial weight loss with obesity interventions, while others receiving these same interventions do not. Person-specific characteristics likely play a significant role in this heterogeneity in treatment response. The practice of precision medicine accounts for an individual's genes, environment, and lifestyle when deciding upon treatment type and intensity in order to optimize benefit and minimize risk. In this review, we first discuss biopsychosocial determinants of obesity, as understanding the complexity of this disease is necessary for appreciating how difficult it is to develop individualized treatment plans. Next, we present literature on person-specific characteristics associated with, and predictive of, weight loss response to various obesity treatments including lifestyle modification, pharmacotherapy, metabolic and bariatric surgery, and medical devices. Finally, we discuss important gaps in our understanding of the causes of obesity in relation to the suboptimal treatment outcomes in certain patients, and offer solutions that may lead to the development of more effective and targeted obesity therapies.

References

Sep 16, 1999·The New England Journal of Medicine·I S FarooqiS O'Rahilly
Dec 29, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·G Di StefanoA Falorni
May 17, 2001·Obesity Surgery·J B DixonP E O'Brien
Jan 18, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A RissanenL Sjöström
Apr 12, 2003·Obesity Research·Elinor Ben-MenachemUlf Smith
Apr 16, 2003·Alimentary Pharmacology & Therapeutics·A UllrichV Schusdziarra
Apr 22, 2003·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Paul A EstabrooksNancy C Gyurcsik
Jul 21, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·P J TeixeiraT G Lohman
Oct 16, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J WildingUNKNOWN OBES-002 Study Group
Jun 9, 2005·The American Journal of Clinical Nutrition·Maria E Valera-MoraEle Ferrannini
Oct 22, 2005·British Journal of Health Psychology·S C Stotland, M Larocque
Jun 27, 2007·Diabetes, Obesity & Metabolism·K ElfhagS Rössner
Dec 14, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·K M KleinH M Hamer
May 22, 2008·The Journal of Pediatrics·Kathy Love-OsbornePhil Zeitler
Aug 22, 2009·Obesity·Pedro J TeixeiraLuís B Sardinha
Nov 28, 2009·Journal of the American Dietetic Association·Riccardo Dalle GraveUNKNOWN QUOVADIS Study Group
Dec 8, 2009·Journal of Pediatric Endocrinology & Metabolism : JPEM·Kristine A MadsenRobert H Lustig
Feb 4, 2010·European Child & Adolescent Psychiatry·Anke HinneyJohannes Hebebrand
Mar 3, 2010·Health Affairs·Gopal K SinghMichael D Kogan
Apr 20, 2010·Behaviour Research and Therapy·Ellen MoensMyriam Van Winckel
Jul 22, 2010·The New England Journal of Medicine·Steven R SmithUNKNOWN Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group
Jul 27, 2010·Diabetes Research and Clinical Practice·Weilin KongJean-Patrice Baillargeon
Sep 23, 2010·International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity·Jean-Pierre Chanoine, Matthew Richard
Nov 30, 2010·Journal of Obesity·Amelia Hollywood, Jane Ogden
Aug 13, 2011·The Journal of Clinical Endocrinology and Metabolism·Ida J HatoumLee M Kaplan
Oct 7, 2011·The Journal of Clinical Endocrinology and Metabolism·Uyenlinh L MirshahiTooraj Mirshahi
Oct 31, 2012·Archives of Pediatrics & Adolescent Medicine·Pernilla DanielssonClaude Marcus
Aug 29, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J MinY Wang
Oct 10, 2013·Clinical Pharmacology and Therapeutics·G W KimS A Waldman
Jul 1, 2011·Obesity Research & Clinical Practice·Masha LivhitsMelinda Maggard Gibbons
Jan 21, 2014·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Katerina KotzampassiVasilis Grosomanidis

❮ Previous
Next ❯

Citations

Apr 12, 2020·International Journal of Environmental Research and Public Health·Tara KellyFrancis Finucane
Dec 10, 2020·Journal of Pediatric Nursing·Nancy T BrowneLinda Lewandowski
Sep 18, 2020·Pediatric Diabetes·Armando PeñaGabriel Q Shaibi

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies
pharmacotherapy
gastric bypass

Software Mentioned

Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Experimental and Therapeutic Medicine
Shumei Xu, Ying Xue
Journal of Women's Health
Zujaja TauqeerFatima Cody Stanford
Endocrinology and Metabolism Clinics of North America
Melissa K Crocker, Jack A Yanovski
Pediatric Clinics of North America
Melissa K Crocker, Jack A Yanovski
© 2021 Meta ULC. All rights reserved